Skip to main content
. 2022 Dec 16;11(24):4078. doi: 10.3390/cells11244078

Table 2.

Detailed statistical characteristics of hormonal parameters in women in the study group (pre-treatment (T1) and post-treatment (T2)) compared to the control group (C).

Variable Group n M SD Mdn IQR Min Max p
testosterone (T1) Study 99 0.53 0.19 0.52 0.30 0.17 0.97 0.001
Control 69 0.31 0.10 0.32 0.13 0.13 0.54
testosterone (T2) Study 99 0.41 0.14 0.38 0.14 0.14 0.85 0.001
androstendione (T1) Study 99 3.87 1.14 3.90 1.60 1.80 6.50 0.001
Control 69 2.36 0.58 2.47 0.73 1.19 3.83
androstendione (T2) Study 99 3.03 0.71 3.10 1.00 1.50 4.50 0.026
SHBG (T1) Study 99 45.99 20.97 44.80 21.92 13.55 129.90 0.001
Control 69 104.79 94.83 66.90 48.70 5.00 414.00
SHBG (T2) Study 99 148.08 38.94 145.10 55.70 78.10 223.10 0.001
FAI (T1) Study 99 1.40 0.86 1.20 0.99 0.38 5.55 0.001
Control 69 0.60 1.22 0.40 0.36 0.05 10.22
FAI (T2) Study 99 0.30 0.14 0.27 0.17 0.11 0.88 0.001
LH (T1) Study
Control
99
69
8.26
9.31
3.88
5.22
8.50
10.2
4.26
5.11
1.07
1.02
15.10
14.3
0.621
FSH (T1) Study 99 5.63 1.81 5.47 2.51 1.64 9.95 0.820
Control 69 5.61 1.84 5.82 2.53 0.30 9.69
PRL (T1) Study 99 20.66 7.99 19.60 13.03 6.75 37.91 0.001
Control 69 17.91 8.33 16.30 8.60 6.16 44.00
DHEA-S (T1) Study 99 258.51 81.79 254.10 119.15 45.60 413.00 0.348
Control 69 239.70 98.19 211.00 151.00 58.40 487.00
ACTH (T1) Study 99 16.57 11.95 15.20 13.35 4.27 89.20 0.001
Control 69 21.21 11.52 18.70 12.90 1.66 67.90
cortisol (T1) Study 99 22.25 9.61 21.00 11.90 8.02 49.10 0.001
Control 69 15.79 7.51 14.30 9.30 5.63 39.50

T1—pre-treatment; T2—post-treatment; N—sample size; M—mean; SD—standard deviation; Mdn—median; IQR—interquartile range; Min—minimum; Max—maximum; pp-value.